Index RUT
P/E -
EPS (ttm) -1.40
Insider Own 2.00%
Shs Outstand 38.77M
Perf Week -8.62%
Market Cap 617.64M
Forward P/E -
EPS next Y -1.33
Insider Trans -4.57%
Shs Float 37.92M
Perf Month -28.14%
Income -52.90M
PEG -
EPS next Q -0.34
Inst Own 99.80%
Short Float / Ratio 4.04% / 1.70
Perf Quarter -53.60%
Sales 162.90M
P/S 3.79
EPS this Y -6.90%
Inst Trans -0.56%
Short Interest 1.53M
Perf Half Y -61.85%
Book/sh 4.01
P/B 3.91
EPS next Y 8.90%
ROA -22.10%
Target Price 33.67
Perf Year -63.75%
Cash/sh 4.78
P/C 3.28
EPS next 5Y 16.20%
ROE -39.60%
52W Range 15.94 - 58.04
Perf YTD -70.33%
Dividend -
P/FCF -
EPS past 5Y -19.10%
ROI -21.90%
52W High -72.98%
Beta 1.19
Dividend % -
Quick Ratio 8.90
Sales past 5Y 57.60%
Gross Margin 71.90%
52W Low -1.63%
ATR 0.85
Employees 414
Current Ratio 9.70
Sales Q/Q 36.40%
Oper. Margin -32.60%
RSI (14) 22.12
Volatility 4.34% 4.32%
Optionable Yes
Debt/Eq 0.48
EPS Q/Q 20.60%
Profit Margin -32.50%
Rel Volume 0.82
Prev Close 15.98
Shortable Yes
LT Debt/Eq 0.48
Earnings Aug 01 AMC
Payout -
Avg Volume 898.38K
Price 15.68
Recom 2.30
SMA20 -16.24%
SMA50 -22.65%
SMA200 -58.61%
Volume 733,182
Change -1.88%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-21-23 Downgrade
Argus
Buy → Hold
Sep-06-23 Initiated
Oppenheimer
Outperform
$30
Jul-12-23 Downgrade
JP Morgan
Overweight → Neutral
$50 → $28
Jul-12-23 Downgrade
BofA Securities
Buy → Underperform
$51 → $28
May-23-23 Initiated
CL King
Buy
$47
May-15-23 Downgrade
Wolfe Research
Peer Perform → Underperform
$27
Apr-03-23 Upgrade
Citigroup
Neutral → Buy
$50
Mar-31-23 Initiated
B. Riley Securities
Buy
$58
Mar-10-23 Upgrade
Citigroup
Sell → Neutral
$50
Feb-07-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Nov-22-22 Initiated
BofA Securities
Buy
$60
Jul-11-22 Downgrade
Citigroup
Neutral → Sell
$33
Apr-06-22 Initiated
Wolfe Research
Outperform
$48
Nov-19-21 Upgrade
Citigroup
Sell → Neutral
$50
Oct-01-21 Downgrade
Citigroup
Neutral → Sell
$50
Oct-01-20 Downgrade
Citigroup
Buy → Neutral
$58 → $71
Aug-21-20 Initiated
Piper Sandler
Neutral
$54
Jul-09-20 Initiated
SVB Leerink
Outperform
$51
May-27-20 Initiated
Citigroup
Buy
$50
Aug-20-19 Initiated
Argus
Buy
$52
Show Previous Ratings
Sep-21-23 10:06AM
Sep-04-23 04:30PM
Aug-11-23 06:19AM
Aug-03-23 04:30PM
Aug-02-23 10:21AM
09:03AM
Loading…
09:03AM
(Thomson Reuters StreetEvents)
Aug-01-23 05:35PM
04:30PM
04:05PM
Jul-13-23 02:25AM
Jul-12-23 12:35PM
08:57AM
Jul-11-23 04:30PM
Jun-30-23 08:31AM
May-22-23 07:09AM
06:54AM
Loading…
06:54AM
May-16-23 03:28AM
May-09-23 06:25PM
05:18PM
04:05PM
May-07-23 08:54AM
May-05-23 09:00AM
May-04-23 04:30PM
Apr-26-23 04:30PM
Apr-18-23 04:30PM
Mar-31-23 10:36AM
08:11AM
Mar-27-23 09:54AM
Mar-02-23 08:29PM
Mar-01-23 07:52AM
(Thomson Reuters StreetEvents) -9.76%
08:05PM
Loading…
Feb-28-23 08:05PM
04:05PM
Feb-07-23 09:00AM
Jan-23-23 12:00PM
Jan-09-23 07:20AM
07:05AM
Dec-30-22 12:46AM
Dec-28-22 04:30PM
Dec-22-22 11:47AM
Dec-12-22 09:15AM
Dec-05-22 12:00PM
Nov-10-22 07:36AM
Nov-08-22 07:35PM
04:05PM
Nov-03-22 04:30PM
Nov-01-22 12:35PM
Oct-25-22 04:30PM
Oct-19-22 01:27PM
Oct-18-22 07:46PM
Oct-17-22 08:03PM
04:25PM
12:53PM
Sep-29-22 07:41AM
Sep-28-22 02:25PM
(Investor's Business Daily) +9.33%
Sep-07-22 04:15PM
Aug-30-22 04:15PM
Jul-27-22 09:31AM
Jul-26-22 05:35PM
04:05PM
Jul-22-22 01:26PM
(Investor's Business Daily)
Jul-12-22 04:15PM
07:07AM
Jun-15-22 09:00AM
Jun-09-22 02:29PM
Jun-02-22 07:00AM
May-31-22 09:00AM
May-10-22 11:21AM
May-04-22 07:35PM
04:05PM
May-02-22 08:30AM
Apr-26-22 04:10PM
Apr-13-22 04:15PM
Feb-24-22 05:40PM
04:01PM
08:12AM
Feb-17-22 03:03PM
Feb-03-22 04:30PM
Feb-02-22 04:30PM
Jan-27-22 10:00AM
Jan-10-22 01:11PM
Jan-07-22 05:38PM
Dec-30-21 04:30PM
Nov-25-21 09:11AM
Nov-16-21 12:22PM
Nov-10-21 04:10PM
12:31AM
Nov-09-21 06:45PM
04:05PM
Nov-03-21 11:34AM
Nov-02-21 04:10PM
03:01PM
Nov-01-21 11:38AM
Oct-21-21 04:10PM
Oct-13-21 11:42AM
Oct-11-21 03:39PM
Oct-06-21 11:30AM
Sep-30-21 11:15AM
08:50AM
Sep-29-21 12:00PM
Sep-15-21 10:50AM
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure. Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Klemz Kevin M EVP/Chief Legal Officer/Sec. Aug 17 Sale 20.11 1,539 30,942 38,797 Aug 18 08:16 PM Davis Andrew S. Chief Commercial Officer Aug 03 Sale 22.13 6,587 145,797 109,534 Aug 04 05:31 PM Buchanan Lucas W. COO/CFO Jul 28 Option Exercise 5.42 9,643 52,229 215,725 Jul 31 05:44 PM Jones Marie L. CAO and VP, Finance Jul 20 Option Exercise 6.11 2,000 12,220 48,002 Jul 21 06:24 PM Rogers Erica J. President and CEO Jul 11 Option Exercise 1.60 1,000 1,600 270,639 Jul 13 06:34 PM Rogers Erica J. President and CEO Jul 11 Sale 31.56 1,000 31,560 269,639 Jul 13 06:34 PM Davis Andrew S. Chief Commercial Officer Jul 06 Sale 30.79 69 2,124 115,614 Jul 10 05:39 PM Rogers Erica J. President and CEO Jun 12 Option Exercise 1.60 1,000 1,600 270,639 Jun 13 08:13 PM Rogers Erica J. President and CEO Jun 12 Sale 32.13 1,000 32,130 269,639 Jun 13 08:13 PM Rogers Erica J. President and CEO May 11 Option Exercise 1.60 3,000 4,800 272,132 May 12 09:37 PM Rogers Erica J. President and CEO May 11 Sale 35.51 3,000 106,530 269,132 May 12 09:37 PM Davis Andrew S. Chief Commercial Officer May 01 Option Exercise 5.90 6,753 39,845 122,436 May 03 06:39 PM Davis Andrew S. Chief Commercial Officer May 01 Sale 44.51 6,753 300,593 115,683 May 03 06:39 PM WEATHERMAN ELIZABETH H Director Apr 17 Sale 41.91 5,000 209,550 144,454 Apr 19 06:14 PM Rogers Erica J. President and CEO Apr 11 Option Exercise 1.60 6,000 9,600 275,132 Apr 12 05:29 PM Rogers Erica J. President and CEO Apr 11 Sale 39.77 6,000 238,635 269,132 Apr 12 05:29 PM Davis Andrew S. Chief Commercial Officer Apr 03 Option Exercise 4.79 6,753 32,372 122,436 Apr 05 05:19 PM Davis Andrew S. Chief Commercial Officer Apr 03 Sale 39.42 6,753 266,203 115,683 Apr 05 05:19 PM WEATHERMAN ELIZABETH H Director Mar 15 Sale 41.91 5,000 209,550 149,454 Mar 17 07:06 PM Rogers Erica J. President and CEO Mar 13 Option Exercise 1.60 6,000 9,600 275,132 Mar 15 06:16 PM Rogers Erica J. President and CEO Mar 13 Sale 42.23 6,000 253,393 269,132 Mar 15 06:16 PM Davis Andrew S. Chief Commercial Officer Mar 06 Sale 47.74 3,868 184,653 115,683 Mar 06 08:19 PM Ruedy Richard EVPClin&Reg.Affairs&QA Mar 06 Sale 47.73 2,373 113,257 145,483 Mar 06 08:20 PM Rogers Erica J. President and CEO Mar 03 Sale 47.10 18,043 849,901 269,132 Mar 06 08:14 PM Buchanan Lucas W. COO/CFO Mar 03 Sale 47.11 9,918 467,193 205,575 Mar 06 08:17 PM Davis Andrew S. Chief Commercial Officer Mar 01 Option Exercise 4.73 6,753 31,942 104,144 Mar 02 09:01 PM Davis Andrew S. Chief Commercial Officer Mar 01 Sale 48.02 6,753 324,272 98,205 Mar 02 09:01 PM WEATHERMAN ELIZABETH H Director Feb 15 Sale 49.86 5,000 249,300 154,454 Feb 17 06:56 PM Rogers Erica J. President and CEO Feb 13 Option Exercise 1.60 6,000 9,600 252,199 Feb 15 06:18 PM Rogers Erica J. President and CEO Feb 13 Sale 50.94 6,000 305,627 246,199 Feb 15 06:18 PM Davis Andrew S. Chief Commercial Officer Feb 01 Option Exercise 4.73 6,753 31,942 104,958 Feb 03 07:19 PM Chou Tony M. Director Feb 01 Sale 55.00 13,008 715,440 75,707 Feb 03 07:14 PM Davis Andrew S. Chief Commercial Officer Feb 01 Sale 54.05 6,753 365,000 98,205 Feb 03 07:19 PM Buchanan Lucas W. COO/CFO Jan 19 Option Exercise 13.90 38,528 535,666 217,289 Jan 19 08:01 PM Buchanan Lucas W. COO/CFO Jan 19 Sale 53.40 41,244 2,202,533 188,811 Jan 19 08:01 PM Buchanan Lucas W. COO/CFO Jan 17 Option Exercise 1.60 45,000 72,000 236,527 Jan 19 08:01 PM WEATHERMAN ELIZABETH H Director Jan 17 Sale 54.69 56,355 3,082,224 159,454 Jan 19 06:44 PM Buchanan Lucas W. COO/CFO Jan 17 Sale 54.68 45,000 2,460,622 191,527 Jan 19 08:01 PM Chou Tony M. Director Jan 13 Sale 55.00 806 44,330 87,709 Jan 17 06:07 PM Chou Tony M. Director Jan 12 Sale 55.00 200 11,000 88,515 Jan 17 06:07 PM Rogers Erica J. President and CEO Jan 11 Option Exercise 1.60 6,000 9,600 252,199 Jan 13 05:32 PM Rogers Erica J. President and CEO Jan 11 Sale 51.53 6,000 309,180 246,199 Jan 13 05:32 PM Davis Andrew S. Chief Commercial Officer Jan 03 Option Exercise 2.33 6,753 15,744 103,380 Jan 04 08:03 PM Davis Andrew S. Chief Commercial Officer Jan 03 Sale 52.87 6,753 357,031 98,205 Jan 04 08:03 PM Buchanan Lucas W. COO/CFO Dec 15 Option Exercise 1.60 15,000 24,000 191,527 Dec 15 08:35 PM Buchanan Lucas W. COO/CFO Dec 13 Option Exercise 1.60 25,000 40,000 201,527 Dec 15 08:35 PM Buchanan Lucas W. COO/CFO Dec 13 Sale 55.00 25,000 1,375,000 176,527 Dec 15 08:35 PM Chou Tony M. Director Dec 13 Sale 55.00 10,060 553,300 88,715 Dec 15 07:00 PM Rogers Erica J. President and CEO Dec 12 Option Exercise 1.60 10,000 16,000 256,199 Dec 14 07:04 PM Rogers Erica J. President and CEO Dec 12 Sale 53.85 10,000 538,501 246,199 Dec 14 07:04 PM Davis Andrew S. Chief Commercial Officer Dec 01 Option Exercise 1.55 6,753 10,457 102,472 Dec 02 06:40 PM Davis Andrew S. Chief Commercial Officer Dec 01 Sale 53.00 6,753 357,909 98,205 Dec 02 06:40 PM Buchanan Lucas W. COO/CFO Nov 11 Option Exercise 1.60 24,800 39,680 201,327 Nov 14 06:24 PM Rogers Erica J. President and CEO Nov 11 Option Exercise 1.60 10,000 16,000 256,199 Nov 14 06:27 PM Buchanan Lucas W. COO/CFO Nov 11 Sale 50.00 24,800 1,240,000 176,527 Nov 14 06:24 PM Rogers Erica J. President and CEO Nov 11 Sale 50.03 10,000 500,309 246,199 Nov 14 06:27 PM Buchanan Lucas W. COO/CFO Nov 09 Option Exercise 1.60 200 320 176,727 Nov 14 06:24 PM Buchanan Lucas W. COO/CFO Nov 09 Sale 50.00 200 10,000 176,527 Nov 14 06:24 PM Davis Andrew S. Chief Commercial Officer Nov 01 Option Exercise 1.46 6,753 9,859 104,958 Nov 01 07:48 PM Davis Andrew S. Chief Commercial Officer Nov 01 Sale 44.17 6,753 298,280 98,205 Nov 01 07:48 PM Rogers Erica J. President and CEO Oct 11 Option Exercise 1.60 10,000 16,000 256,199 Oct 13 06:58 PM Rogers Erica J. President and CEO Oct 11 Sale 42.32 10,000 423,218 246,199 Oct 13 06:58 PM Davis Andrew S. Chief Commercial Officer Oct 03 Option Exercise 1.46 6,753 9,859 104,958 Oct 05 08:36 PM Davis Andrew S. Chief Commercial Officer Oct 03 Sale 44.76 6,753 302,264 98,205 Oct 05 08:36 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite